ORG Wealth Partners’s Ascendis Pharma A/S ASND Stock Holding History

ORG Wealth Partners’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9K	Hold	56	–	–	﹤0.01%	479
2026 Q1	$12.8K	Buy	56 +29	+107%	+$6.5K	﹤0.01%	469
2025 Q4	$5.76K	Buy	27 +2	+8%	+$413	﹤0.01%	506
2025 Q3	$4.97K	Hold	25	–	–	﹤0.01%	522
2025 Q2	$4.3K	Buy	+25	New	+$4.07K	﹤0.01%	560

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ORG Wealth Partners's ASND Position: Q2 2026 in Review

ORG Wealth Partners held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 56 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

ORG Wealth Partners first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

ORG Wealth Partners held 56 shares of Ascendis Pharma A/S worth $14.9K as of Q2 2026.
ORG Wealth Partners left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up ﹤0.01% of ORG Wealth Partners's portfolio in Q2 2026, its #479 holding.
ORG Wealth Partners first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.